rxstat › Shortages › Acarbose

Acarbose (Glucobay) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Acarbose products have been discontinued in Canada. See the reports below for which products and when.

An oral medication used to help control blood sugar in type 2 diabetes.

Products affected

0 / 2

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Discontinued

GLUCOBAY

50MG · TABLET · BAYER INC

DIN 02190885

Discontinued

GLUCOBAY

100MG · TABLET · BAYER INC

DIN 02190893

Resolved

GLUCOBAY

100MG · TABLET · BAYER INC

DIN 02190893 · ended Jul 10, 2023 · DIN discontinued

Resolved

GLUCOBAY

50MG · TABLET · BAYER INC

DIN 02190885 · ended Jul 10, 2023 · DIN discontinued.

Resolved

GLUCOBAY

100MG · TABLET · BAYER INC

DIN 02190893 · ended Feb 5, 2020 · Disruption of the manufacture of the drug.

Resolved

GLUCOBAY

50MG · TABLET · BAYER INC

DIN 02190885 · ended Jul 24, 2019 · Disruption of the manufacture of the drug.

Resolved

GLUCOBAY

50MG · TABLET · BAYER INC

DIN 02190885 · ended Sep 14, 2017 · Disruption of the manufacture of the drug.

Resolved

GLUCOBAY

100MG · TABLET · BAYER INC

DIN 02190893 · ended Aug 24, 2017 · Disruption of the manufacture of the drug.

What's happening

One or more Acarbose products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Acarbose is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BF).

Recent changes

No changes recorded yet.

Common questions

What is Acarbose used for?

An oral medication used to help control blood sugar in type 2 diabetes.

When will Acarbose be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Acarbose in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (blood glucose lowering drugs, excl. insulins)

Canagliflozin Widespread shortage 2 of 4 reported products affected · est. return Jan 8, 2027 Tirzepatide (Mounjaro) Widespread shortage 6 of 6 reported products affected Dapagliflozin Partial shortage 4 of 11 reported products affected Dapagliflozin Metformin (Xigduo) Partial shortage 2 of 6 reported products affected · est. return Dec 4, 2026 Gliclazide (Diamicron Mr) Partial shortage 2 of 20 reported products affected Metformin (Glucophage) Partial shortage 3 of 33 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.